Joonghun Pharmaceutical

Joonghun Pharmaceutical, through relentless R&D investment, will build their own technological innovation capabilities and provide channels for global customers. To achieve this goal, they have obtained patents for leading compounds used in the treatment of osteoarthritis and continue to advance.Other companies have developed and consistently supplied the market with hyaluronic acid products such as "Artgaon," "Lufla," and many others through their pre-filled syringe production line. Joonghun Pharmaceutical will focus on developing a new generation of dermal fillers and biopharmaceutical products.Joonghun Pharmaceutical will further enhance their strength through innovation by proactively facing new challenges.